Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | CDC25A | P30304 | 1/20 | 0.58 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.58 |
| ▸ | AKT1 | P31749 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | CETP | P11597 | 3/20 | 0.50 |
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | PTAFR | P25105 | 1/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14000864 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL19458808 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL27699112 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL20482670 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL20483366 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL12235520 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL27542770 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL28786169 | 0.98 | LMNA (0.56) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL29267508 | 0.91 | LPAR3 (0.53) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL27747029 | 0.91 | LPAR3 (0.53) | LMNAESR1ADORA3CDC25AAGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102413-A1 | MULTIVALENT TUBERCULOSIS VACCINE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-3586142-B1 | DETECTION OF MEMBRANE PROTEINS | UNIV OXFORD INNOVATION LTD (GB) | 2024-12-25 | — | — | EP | disclosed |
| US-20230102836-A1 | Amoebicidal Compositions for Contact Lens Solutions | UNIVERSITY OF THE WEST OF SCOTLAND (GB) | 2023-03-30 | — | — | US | disclosed |
| US-10955421-B2 | Detection of membrane proteins | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2021-03-23 | — | — | US | disclosed |
| EP-3229811-B1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GRI BIO INC (US) | 2021-02-24 | — | — | EP | disclosed |
| US-20200240997-A1 | DETECTION OF MEMBRANE PROTEINS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2020-07-30 | — | — | US | disclosed |
| CN-111432846-A | Semiconductor SWCNT dispersion for bioimaging and method for producing same | 株式会社岛津制作所 | 2020-07-17 | — | — | CN | disclosed |
| CN-111356481-A | Semiconductor SWCNT dispersion for bioimaging and method for examining the same | 株式会社岛津制作所 | 2020-06-30 | — | — | CN | disclosed |
| WO-2019229086-A1 | ELECTROCHEMICAL BIOENZYMATIC SENSOR FOR MEASURING H2S IN BIOLOGICAL FLUIDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2019-12-05 | — | — | WO | disclosed |
| CN-105294855-A | Preparation method of non-phospholipid nanodisc | VIVA BIOTECH LTD | 2016-02-03 | — | — | CN | disclosed |
| CN-1875934-A | Anticancer drug sustained-release injection carrying clorfarabine and synergist thereof | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2006-12-13 | — | — | CN | disclosed |
| CN-1861050-A | Anticancer drug sustained-release injection loaded with platinum compound and synergist thereof | LANJIN BIOENGINEERING CO LTD S (CN) | 2006-11-15 | — | — | CN | disclosed |
| CN-1861049-A | Anticancer drug sustained-release injection containing gemcitabine | LANJIN BIOENGINEERING CO LTD S (CN) | 2006-11-15 | — | — | CN | disclosed |
| CN-1850039-A | Compound platinum medicine slow-release agent | SHUAIHUA MEDICINE SCIENCE TECH (CN) | 2006-10-25 | — | — | CN | disclosed |
| CN-1846679-A | Sustained-release injection containing methotrexate and synergist thereof | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | disclosed |
| CN-1846676-A | Sustained-release injection containing fluorouracil synergist and preparation method thereof | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | disclosed |
| CN-1846673-A | Slow-released anticancer medicine prepn containing pyrimidine medicine | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | disclosed |
| CN-1846687-A | Slow-release agent containing taxane and synergist thereof | JINAN KANGQUAN MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | disclosed |
| CN-1733303-A | Anticancer implantation agent containing blood vessel inhibitor | KONG QINGZHONG (CN) | 2006-02-15 | — | — | CN | disclosed |
| CN-1628851-A | Anti-cancer medicine composition | KONG QINGZHONG (CN) | 2005-06-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200240997-A1 | DETECTION OF MEMBRANE PROTEINS | CETP, VAPA, PCTP | LMNA 1166/4885ESR1 3145/4885ADORA3 4602/4885 |
| US-10955421-B2 | Detection of membrane proteins | CETP, VAPA, PCTP | LMNA 1166/4885ESR1 3145/4885ADORA3 4602/4885 |
| US-20230102836-A1 | Amoebicidal Compositions for Contact Lens Solutions | APH1B, PHOSPHO1, UACA | LMNA 635/4885ESR1 4665/4885ADORA3 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.